🇺🇸 FDA
Patent

US 9080175

Organic compositions to treat Beta-ENaC-related diseases

granted A61KA61K31/713A61P

Quick answer

US patent 9080175 (Organic compositions to treat Beta-ENaC-related diseases) held by Arrowhead Research Corporation expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Research Corporation
Grant date
Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/713, A61P, A61P1/00, A61P1/18